Skip to main content

Table 1 Patient demographic and clinical characteristics

From: Relationship between gene expression profile class and tumor thickness regression after plaque brachytherapy for choroidal melanoma

Patient #

Age

Sex

Eye involved

Initial thickness (mm)

AJCC tumor staging

GEP class

1

60

M

R

5.53

T2aN0M0, stage IIA

2

2

59

M

R

7.4

T2aN0M0, stage IIA

1 A

3

67

M

L

4.4

T3aN0M0, stage IIB

2

4

65

F

L

3.5

T1aN0M0, stage I

1 A

5

62

M

L

4.36

T2aN0M0, stage IIA

1B

6

65

M

R

3.6

T1aN0M0, stage I

1B

7

46

M

R

4

T2aN0M0, stage IIA

1B

8

37

M

R

3.13

T2aN0M0, stage IIA

1A

9

68

M

L

4.11

T1aN0M0, stage I

2

10

77

F

L

4.51

T2aN0M0, stage IIA

1A

11

68

F

R

5.5

T2aN0M0, stage IIA

1A

12

68

F

L

3.73

T1aN0M0, stage I

1A

13

71

F

R

8.67

T3cN0M0, stage IIIA

2

14

73

M

R

3.32

T2aN0M0, stage IIA

2

15

66

M

R

3.96

T2aN0M0, stage IIA

1B